Table 2.
Treatment | Prevalence | P-value |
---|---|---|
1st Line drug treatment | 15/62 (24.2%) | |
2nd Line drug treatment | 5/50 (10%) | 0.022* |
Naïve | 7/61 (11.5%) | |
Controls | 4/50 (8%) | χ2 = 9.6 |
Overall prevalence | 31/223 (13.9%) |
*Statistically significant.
Treatment | Prevalence | P-value |
---|---|---|
1st Line drug treatment | 15/62 (24.2%) | |
2nd Line drug treatment | 5/50 (10%) | 0.022* |
Naïve | 7/61 (11.5%) | |
Controls | 4/50 (8%) | χ2 = 9.6 |
Overall prevalence | 31/223 (13.9%) |
*Statistically significant.